DiaSys respons®c line

Trusted analytical solutions for reliable results

Discover the perfect solution for every laboratory size. Due to its compact design respons®240c is ideal for small labs that require an analyzer capable of a constant throughput of 240 tests/hour along with intuitively operated software. Advanced features like onboard hemolysis and a grated photometer with 12 wavelengths ensure precision and efficiency.

AMSBIO plating beads

Novel plating beads improve microbialcolony formation efficiency

A new sterile bead-based plating method offers enhanced efficiency and safety for microbiological work, potentially improving laboratory throughput and reproducibility.

CN Bio PhysioMimix assay kit

CN Bio’s new bioavailability assay kit enhances drug development process

Cambridge-based organ-on-chip technology company CN Bio has introduced a new in vitro assay kit designed to assess human oral drug bioavailability. The PhysioMimix Bioavailability assay kit: Human 18 enables pharmaceutical researchers to generate predictive human data earlier in the drug development pipeline, reducing reliance on animal studies.

Scherm­afbeelding 2025 01 24 om 11.31.34

Enhanc3D Genomics platform expands capabilities for drug development

Cambridge-based Enhanc3D Genomics has unveiled an integrated suite of multi-omics solutions designed to enhance drug discovery processes. The platform, which leverages proprietary Promoter Capture Hi-C technology, enables high-resolution mapping of genomewide regulatory interactions to support more targeted therapeutic development approaches.

Scherm­afbeelding 2025 01 24 om 09.17.50

clinical laboratory international

clinical laboratory international

AdobeStock 554402509

Flow cytometry technique identifies disease and therapy-associated microbial signatures in Crohn’s disease

Background Recent research suggests that the incidence of inflammatory bowel disease (IBD) in the UK is 1 in every 123 people, and that previously these numbers have been largely underestimated.

AdobeStock 781859776

Reducing KAT7 expression inhibits colorectal cancer progression

Colorectal cancer background and risk factors Colorectal (or bowel) cancer (CRC) is cancer anywhere in the colon (the large intestine) or the rectum.

Scherm­afbeelding 2025 01 23 om 13.39.50

BioRad | InteliQ. Simply Smarter QC.

Simplify your QC workflow with load-and-go efficiency and robust data management.

Scherm­afbeelding 2025 01 23 om 13.38.27

β-Hydroxybutyrate 21 FS

Best choice for reliable ketosis management

Scherm­afbeelding 2025 01 23 om 13.36.21

Medlab Middle East

Empowering today’s Medical Labs for tomorrow’s Global Future